Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trial

Tracy Stockley(University Health Network), Philippe L. Bédard(Princess Margaret Cancer Centre)

Genome Medicine

October 25, 2016

10.1186/s13073-016-0364-2

Cited by 283

Related Papers

A phase Ib combination study of RO4929097, a gamma-secretase inhibitor, and temsirolimus in patients with advanced solid tumors

|Investigational New Drugs|2013|56

First‐in‐human trial of the PI3Kβ‐selective inhibitor SAR260301 in patients with advanced solid tumors

|Cancer|2017|34